SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950116-01-500062
Filing Date
2001-04-27
Accepted
2001-04-27 00:00:00
Documents
2
Period of Report
2001-04-23
Items
Item 4: Changes in registrant's certifying accountant
Item 7: Financial statements and exhibits

Document Format Files

Seq Description Document Type Size
1 8-K eightk.txt 8-K 3395
2 EXHIBIT 16 ex16.txt EX-16 456
  Complete submission text file 0000950116-01-500062.txt   5426
Mailing Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO M5J A1
Business Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CANA A1 4163642551
GENEREX BIOTECHNOLOGY CORP (Filer) CIK: 0001059784 (see all company filings)

IRS No.: 820490211 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-25169 | Film No.: 1614161
SIC: 2834 Pharmaceutical Preparations